Complementary animal experiments reinforced the significant role of Ruthenibacterium lactatiformans and ILA in mitigating obesity, glucose intolerance, and dyslipidemia induced by a high-fat diet (HFD). This evidence concerns the gene TNFRSF9 and obesity disorder.